Avalo Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo’s pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
/ 
Frequently asked questions
To buy Avalo Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Avalo Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Avalo Therapeutics Inc. is AVTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Avalo Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Avalo Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Avalo Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Avalo Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Avalo Therapeutics Inc..